Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 31/74 ]
NYSE | Common Stock
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.
It operates through two segments, Surgical and Vision Care.
The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert.
In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure.
Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers.
The company was formerly known as Alcon UniversalS. A. and changed its name to Alcon Inc. in December 2001.
Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 25, 25 | 0.72 Increased by +4.35% | 0.72 Increased by +0.57% |
| Nov 12, 24 | 0.53 Decreased by -19.94% | 0.74 Decreased by -29.04% |
| Aug 20, 24 | 0.74 Increased by +7.25% | 0.73 Increased by +1.37% |
| May 13, 24 | 0.78 Increased by +11.43% | 0.73 Increased by +6.85% |
| Feb 27, 24 | 0.69 Increased by +64.29% | 0.68 Increased by +1.47% |
| Nov 14, 23 | 0.66 Increased by +32.00% | 0.67 Decreased by -1.49% |
| Aug 15, 23 | 0.69 Increased by +9.52% | 0.64 Increased by +7.81% |
| May 9, 23 | 0.70 Increased by +2.94% | 0.60 Increased by +16.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 2.50 B Increased by +0.95% | 284.00 M Decreased by -33.49% | Increased by +11.35% Decreased by -34.11% |
| Sep 30, 24 | 2.45 B Increased by +5.37% | 263.00 M Increased by +28.92% | Increased by +10.72% Increased by +22.35% |
| Jun 30, 24 | 2.51 B Increased by +3.68% | 223.00 M Increased by +31.95% | Increased by +8.88% Increased by +27.27% |
| Mar 31, 24 | 2.46 B Increased by +4.55% | 248.00 M Increased by +42.53% | Increased by +10.09% Increased by +36.33% |
| Dec 31, 23 | 2.48 B Increased by +14.16% | 427.00 M Increased by +540.21% | Increased by +17.23% Increased by +485.59% |
| Sep 30, 23 | 2.33 B Increased by +8.83% | 204.00 M Increased by +75.86% | Increased by +8.76% Increased by +61.59% |
| Jun 30, 23 | 2.42 B Increased by +9.25% | 169.00 M Increased by +14.19% | Increased by +6.98% Increased by +4.52% |
| Mar 31, 23 | 2.35 B Increased by +7.45% | 174.00 M Increased by +3.57% | Increased by +7.40% Decreased by -3.61% |